Nonspecific
immunotherapy with OK-432, penicillin and heat treated lyophilized powder of Su-strain of streptococcus pyogenes A3, was evaluated in patients with recurrent or unresectable malignant tumors at various diges tive organs to assess the relative benefit of the preparation administered by different routes.
Comparative studies were made of the survival period, the variation in immunological parameters, and the incidence of adverse reactions in two groups of patients with uniform background factors: 30 receiving the preparation intradermally and 21 receiving intramuscular doses of the pre paration.
The survival rate was significantly higher (P=0.001) for patients receiving intradermal than those receiving intramuscular doses of the pre paration.
In the former group, serious adverse reaction was not found but more marked improvement was achieved in various immunological param eters examined.
The results of the present study showed that the preparation is of greater value when it is administered intradermally than intramuscularly to treat malignant tumor at various digestive organs. Table 1 Background factors comparability of the two treatment groups NS: not significant count categorized to normal (4,000-10,000 mm3), sub and supernormal. A nor mal peripheral blood leukocyte count was significantly more common in patients treated intradermally than in those treated intramuscularly (Table 2) . merit in the former group. Consequently there was no significant difference in this respect between 2 groups at 1 and 2 months of the treatment (Table 3) .
T-cell rate in peripheral blood lymphocytes
Prior to the treatment, no significant difference existed between 2 groups with regard to the number of patients with a normal T-cell rate (65 per cent or above) of peripheral blood lymphocytes. In the course of the treatment, the value for this parameter was higher in patients treated intradermally than in those treated intramuscularly. The T-cell rate was significantly different at 2 months of the treatment (Table 4) . (Table  5) .
PHA skin test
In both groups treated with the preparation, the incidence of positive PHA skin test, which was defined as an average diameter of erythema measured more than 25 mm, increased. There was no significant difference between 2 groups in this respect (Table 6 ). An average diameter of erythema measured more than 10 mm or over was regarded as positive Su-PS skin test. In the incidence of a positive test, no significant difference was present between the groups prior to the treatment. During the treatment, the incidence of positive test was higher in patients receiving intradermal doses than in those receiving intramuscular doses of the preparation (Table 7) .
Agglutinin titer
The incidence of positive agglutination reaction, which was defined as more than 64 times of agglutinin titer increased in both groups during the course of the treatment with the preparation and a more marked increase was observed at 2 months of the treatment in patients given intradermal doses than in those given intramuscular doses, the difference albeit not significant (Table  8) . Table 8 Changes in percentages of patients with positive serum agglutinin titers to streptococci Positive agglutinin titer was defined as an agglutinin titer of 64X or over. NS: not significant I.G.: intradermal injection group I.M.: intramuscular injection group with those receiving intramuscular injections is shown in Figure 1 . 
